Literature DB >> 8991936

Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors.

B C Dow1, I Buchanan, H Munro, E A Follett, F Davidson, L E Prescott, P L Yap, P Simmonds.   

Abstract

HCV antibody screening of 624,910 blood donations resulted in 3,832 samples being referred for confirmation. All were tested by RIBA-3 with 2,710 negative, 945 indeterminate and 177 positive results. HCV RNA was detected by PCR in an average of 69.5% of RIBA-3 positives (4 bands 84.1%; 3 bands 74.1%; 2 bands 34.1%) and only 0.53% of RIBA-3 indeterminates. Eighty-four percent of samples with a total RIBA-3 band intensity score (maximum 16) of > or = 8 were PCR positive compared with only 22% of those with a score of < 8. Total mean band intensities for HCV genotype 1 samples (n = 65) were 13.2, genotype 2 (n = 17) 11.4 and genotype 3 (n = 65) 11.2 with type 1 samples showing greater reactivity with c100 and c33 antibodies. No PCR positive type 1 samples were found with RIBA-3 total band scores less than 8, no PCR positive type 2 samples less than 6, whilst PCR positive type 3 samples were found with scores as low as 2. NS5 indeterminates were the most common (40.2%) single band pattern but yielded no PCR positive samples, followed by c33 (23.3%) with one PCR positive and c100 (20.2%) with one PCR positive whilst c22 indeterminates were least common (16.3%) but included three PCR positive donors. All five RIBA-3 indeterminate PCR positive donors were type 3.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8991936     DOI: 10.1002/(SICI)1096-9071(199606)49:2<132::AID-JMV10>3.0.CO;2-G

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis.

Authors:  S J Hutchinson; D J Goldberg; M King; S O Cameron; L E Shaw; A Brown; J MacKenzie; K Wilson; L MacDonald
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

2.  Antigenic heterogeneity of the hepatitis C virus NS5A protein.

Authors:  Xiao-Guang Dou; Ganesh Talekar; Joy Chang; Xing Dai; Lixia Li; Maria-Teresa Bonafonte; Brian Holloway; Howard A Fields; Yury E Khudyakov
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 3.  Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays.

Authors:  Ekta Gupta; Meenu Bajpai; Aashish Choudhary
Journal:  Asian J Transfus Sci       Date:  2014-01

4.  True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India.

Authors:  Sunita Tulsiani; Nabajyoti Choudhury; Priti Desai; Ripal Shah; Ankit Mathur; V Harimoorthy; Jwalant Shah
Journal:  Asian J Transfus Sci       Date:  2012-07

5.  Common molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.

Authors:  Sanja Glišić; David P Cavanaugh; Krishnan K Chittur; Milan Sencanski; Vladimir Perovic; Tijana Bojić
Journal:  BMC Bioinformatics       Date:  2016-03-22       Impact factor: 3.169

Review 6.  Genotyping & diagnostic methods for hepatitis C virus: A need of low-resource countries.

Authors:  Anoop Kumar; Manoj Kumar Rajput; Deepika Paliwal; Aakanksha Yadav; Reba Chhabra; Surinder Singh
Journal:  Indian J Med Res       Date:  2018-05       Impact factor: 2.375

7.  Study of Hepatitis C Virus Detection Assays.

Authors:  Mithaq Sabeeh Khudur Al-Nassary; Batool Mutar Mahdi
Journal:  Ann Med Surg (Lond)       Date:  2018-10-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.